Next-Gen qPCR Systems Boost Multiplex PCR Assays With Advanced Automation Industry Trends Gaining Momentum in the Global Multiplex PCR Assays Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Multiplex PCR Assays Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent years, the market for multiplex pcr assays has seen significant growth. The market is set to increase from $1.51 billion in 2024 to a value of $1.72 billion in 2025, with an annual compound growth rate of 13.6%. The historic growth can be accredited to several factors such as the heightened prevalence of contagious diseases, an increase in governmental funding and backing, escalating usage in clinical diagnostic sectors, the boom in genetic testing and personalized-tailored medicine, a surge in applications within academic and research establishments, betterments in bioinformatics & data analysis instruments and an escalation in healthcare expenses.

Multiplex PCR Assays Market Size Forecast: What's the Projected Valuation by 2029?
The market for multiplex pcr assays is anticipated to experience accelerated growth in the upcoming years, swelling to $2.83 billion by 2029 with a CAGR of 13.4%. This growth during the forecasted period is likely to be driven by factors such as diversification of application areas, increasing demand for point-of-care diagnostic tools, progress in personalized medicine, augmented expenditure in research and development, elevated health consciousness and preventive health practices, the intensified focus on precision therapies, and a surge in demand for accurate and quick diagnostic tests. The forecast period is set to observe major trends including the integration of next-generation sequencing (NGS), companion diagnostic methods, advancements in digital PCR technology, automation and high-throughput systems, the prominence of point-of-care and mobile devices, adaptability and multiplexing capabilities, the application of artificial intelligence and machine learning, improved data management, and utilization of cloud-based solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report

What Are the Drivers Transforming the Multiplex PCR Assays Market?
The multiplex PCR assay market is projected to expand due to the growing demand for diagnostic tests. Diagnostic testing, consisting of procedures or assessments to ascertain the presence or absence of a particular disease or ailment in an individual, has seen a surge in demand. This is largely due to a rise in chronic diseases like cancer and diabetes, necessitating timely and precise diagnoses for effective treatment. An emphasis on preventive healthcare is also driving an increase in regular testing to identify potential health risks earlier. Multiplex PCR assays enhance the efficacy and comprehensiveness of diagnostic tests by enabling concurrent detection and assessment of several pathogens or genetic markers from a single specimen. For example, the National Health Service (NHS), a hospital and healthcare provider based in the UK, reported in July 2024 that diagnostic activities surpassed the levels of 2023, demonstrating a 21% increase in conducted tests in May 2024 compared to the same month the previous year. They also reported that around 2.4 million diagnostic tests were performed in May 2024 alone. Hence, the mounting demand for diagnostic testing is expected to fuel the growth of the multiplex PCR assay market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18681&type=smp

What Long-Term Trends Will Define the Future of the Multiplex PCR Assays Market?
Leading firms in the multiplex PCR assays market are steering their focus towards integrating automation, for instance, the next-generation quantitative PCR (qPCR) systems. These systems enhance the accuracy and flexibility of nucleic acid quantification, which are crucial for refined clinical diagnostics and public health. They provide high-throughput, correct, and simultaneous detection of multiple targets, thereby improving diagnostic precision and efficiency. An example of this is the November 2023 launch of the LightCycler PRO System by Roche Diagnostics Corporation, a diagnostic system solutions manufacturer based in Switzerland. This innovative qPCR platform offers high-throughput, exact, and simultaneous detection of several targets. With improved temperature uniformity, cutting-edge software, and compatibility with over 260 assays, it significantly enhances diagnostic efficiency and accuracy. This system represents the merge of automation in the multiplex PCR assays market, pushing the boundaries of clinical diagnostics and public health.

Which Segments in the Multiplex PCR Assays Market Offer the Most Profit Potential?
The multiplex pcr assays market covered in this report is segmented -

1) By Assay Type: Planar Assay, Bead Based Assay
2) By Product And Services: Consumables, Instruments, Software And Services
3) By Application: Disease Diagnosis, Research And Development, Other Applications
4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users

Subsegments:
1) By Planar Assay: Microarray-Based Assays, Dna Chip-Based Assays
2) By Bead Based Assay: Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18681&type=smp

Which Firms Dominate the Multiplex PCR Assays Market by Market Share and Revenue in 2025?
Major companies operating in the multiplex PCR assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton inson and Company, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, Quanterix Corporation, NanoString Technologies, Standard BioTools Inc, Enzo Biochem Inc, SeraCare Life Sciences Inc, Agena Bioscience, Fluidigm Corporation

Which Regions Offer the Highest Growth Potential in the Multiplex PCR Assays Market?
North America was the largest region in the multiplex PCR assays market in 2024. The regions covered in the multiplex PCR assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18681

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.